https://www.cslbehring.co.jp/ 1.0000 2025-07-28 https://www.cslbehring.co.jp/global-selector 0.5000 2023-12-15 https://www.cslbehring.co.jp/our-company 0.5000 2023-11-30 https://www.cslbehring.co.jp/patients 0.5000 2023-11-30 https://www.cslbehring.co.jp/medical-professionals 0.5000 2025-04-24 https://www.cslbehring.co.jp/newsroom 0.5000 2026-03-20 https://www.cslbehring.co.jp/careers 0.5000 2025-05-14 https://www.cslbehring.co.jp/partnering 0.5000 2023-11-30 https://www.cslbehring.co.jp/contact-us 0.5000 2024-10-23 https://www.cslbehring.co.jp/terms-of-use 0.5000 2018-08-30 https://www.cslbehring.co.jp/sitemap 0.5000 2018-08-22 https://www.cslbehring.co.jp/search 0.5000 2020-04-30 https://www.cslbehring.co.jp/cookie-policy 0.5000 2021-12-23 https://www.cslbehring.co.jp/our-company/our-history 0.5000 2018-09-20 https://www.cslbehring.co.jp/our-company/japan-office-access-map 0.5000 2018-11-15 https://www.cslbehring.co.jp/our-company/transparency-guidelines 0.5000 2018-11-05 https://www.cslbehring.co.jp/our-company/transparency-guidelines-for-patient-organizations 0.5000 2026-02-02 https://www.cslbehring.co.jp/our-company/plasma-derivatives 0.5000 2018-09-06 https://www.cslbehring.co.jp/our-company/worldwide-locations 0.5000 2021-02-22 https://www.cslbehring.co.jp/our-company/suffering-in-silence 0.5000 2020-07-30 https://www.cslbehring.co.jp/our-company/transparency-guidelines/payments-to-medical-institutions 0.5000 2018-09-20 https://www.cslbehring.co.jp/medical-professionals/academic-education-support 0.5000 2023-11-30 https://www.cslbehring.co.jp/medical-professionals/investigator-initiated-studies 0.5000 2025-06-18 https://www.cslbehring.co.jp/newsroom/2019 0.5000 2021-02-19 https://www.cslbehring.co.jp/newsroom/2020 0.5000 2021-02-19 https://www.cslbehring.co.jp/newsroom/2021 0.5000 2021-02-19 https://www.cslbehring.co.jp/newsroom/2022 0.5000 2022-01-16 https://www.cslbehring.co.jp/newsroom/2023 0.5000 2023-01-26 https://www.cslbehring.co.jp/newsroom/2024 0.5000 2024-05-16 https://www.cslbehring.co.jp/newsroom/2025 0.5000 2025-02-11 https://www.cslbehring.co.jp/newsroom/2026 0.5000 2026-01-29 https://www.cslbehring.co.jp/newsroom/2018 0.5000 2018-09-10 https://www.cslbehring.co.jp/newsroom/2017 0.5000 2018-09-10 https://www.cslbehring.co.jp/newsroom/2016 0.5000 2018-09-10 https://www.cslbehring.co.jp/newsroom/2019/190326-hizentra-press-release 0.5000 2019-03-26 https://www.cslbehring.co.jp/newsroom/2019/190326-privigen-press-release 0.5000 2019-04-22 https://www.cslbehring.co.jp/newsroom/2019/190425-privigen-pid-sid-submission 0.5000 2019-04-25 https://www.cslbehring.co.jp/newsroom/2019/190725_cidp-patients-site 0.5000 2019-07-25 https://www.cslbehring.co.jp/newsroom/2019/190807_csl-hq-relocation 0.5000 2019-08-19 https://www.cslbehring.co.jp/newsroom/2019/190814-fy-results 0.5000 2019-08-19 https://www.cslbehring.co.jp/newsroom/2019/190821_idelvion3500_approval 0.5000 2019-08-21 https://www.cslbehring.co.jp/newsroom/2019/191001-physicians-page 0.5000 2019-10-01 https://www.cslbehring.co.jp/newsroom/2019/191203_idelvion3500_launch 0.5000 2019-12-03 https://www.cslbehring.co.jp/newsroom/2019/191217_graphic-facilitation-ws 0.5000 2019-12-18 https://www.cslbehring.co.jp/newsroom/2019/191223_santa-run 0.5000 2019-12-23 https://www.cslbehring.co.jp/newsroom/2019/200109_hem-device 0.5000 2020-01-09 https://www.cslbehring.co.jp/newsroom/2019/200212_1920hy_results 0.5000 2020-02-17 https://www.cslbehring.co.jp/newsroom/2019/200213_cidp-physicians-web-page 0.5000 2020-02-13 https://www.cslbehring.co.jp/newsroom/2019/20190101-example-press-release 0.5000 https://www.cslbehring.co.jp/newsroom/2019/20190213-half-year-result 0.5000 2019-02-15 https://www.cslbehring.co.jp/newsroom/2019/20190213-half-year-result-html-tidy 0.5000 https://www.cslbehring.co.jp/newsroom/2019/20190227-rdd-press-release 0.5000 2019-02-27 https://www.cslbehring.co.jp/newsroom/2019/csl-behring-japan-office 0.5000 2019-07-01 https://www.cslbehring.co.jp/newsroom/2019/test-video-privigen-press-release 0.5000 https://www.cslbehring.co.jp/newsroom/2020/200228_rdd 0.5000 2020-02-28 https://www.cslbehring.co.jp/newsroom/2020/200313_facebooklaunch 0.5000 2020-03-13 https://www.cslbehring.co.jp/newsroom/2020/200316_20th-anniversary 0.5000 2020-03-16 https://www.cslbehring.co.jp/newsroom/2020/200319_coronavirus 0.5000 2020-03-31 https://www.cslbehring.co.jp/newsroom/2020/200330_coronavirus_2 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2020/200406_coronavirus-alliance 0.5000 2020-05-31 https://www.cslbehring.co.jp/newsroom/2020/200406_pg25_cidp 0.5000 2020-04-06 https://www.cslbehring.co.jp/newsroom/2020/200428_coronavirus_global 0.5000 2020-04-28 https://www.cslbehring.co.jp/newsroom/2020/200508_coronavirus_alliance_2 0.5000 2020-05-08 https://www.cslbehring.co.jp/newsroom/2020/200512_cidp-patients-web-page 0.5000 2020-05-12 https://www.cslbehring.co.jp/newsroom/2020/200527_pg25_pidsid 0.5000 2020-09-08 https://www.cslbehring.co.jp/newsroom/2020/200716_eiu-launch 0.5000 2020-07-21 https://www.cslbehring.co.jp/newsroom/2020/200731_org_change 0.5000 2020-07-31 https://www.cslbehring.co.jp/newsroom/2020/200807_whitehouseroundtable 0.5000 2020-08-07 https://www.cslbehring.co.jp/newsroom/2020/200819_csl_1920fy_results 0.5000 2020-08-21 https://www.cslbehring.co.jp/newsroom/2020/200821_idelvion21day_approval 0.5000 2020-08-21 https://www.cslbehring.co.jp/newsroom/2020/201009_covig19_alliance 0.5000 2020-10-09 https://www.cslbehring.co.jp/newsroom/2020/201012_nobel_behring 0.5000 2020-10-12 https://www.cslbehring.co.jp/newsroom/2020/201225_santa_run 0.5000 2020-12-25 https://www.cslbehring.co.jp/newsroom/2020/20200221_privigen_pidsid-approval 0.5000 2020-02-21 https://www.cslbehring.co.jp/newsroom/2021/210218_rdd 0.5000 2021-04-16 https://www.cslbehring.co.jp/newsroom/2021/210514_hae_day_short_movie 0.5000 2021-05-14 https://www.cslbehring.co.jp/newsroom/2021/210525_hae_consortium 0.5000 2021-05-25 https://www.cslbehring.co.jp/newsroom/2021/210624_asrid_survey 0.5000 2021-06-24 https://www.cslbehring.co.jp/newsroom/2021/210630_hem_b_campaign 0.5000 2021-06-30 https://www.cslbehring.co.jp/newsroom/2021/210713_cidp_mylife_line_account 0.5000 2021-07-13 https://www.cslbehring.co.jp/newsroom/2021/210713_youtube_channel_open 0.5000 2021-07-13 https://www.cslbehring.co.jp/newsroom/2021/210728_hem_b_website 0.5000 2021-08-11 https://www.cslbehring.co.jp/newsroom/2021/210818_csl_2021fy_results 0.5000 2021-08-23 https://www.cslbehring.co.jp/newsroom/2021/210928_hemb_website_collaboration 0.5000 2021-09-30 https://www.cslbehring.co.jp/newsroom/2021/211216_great_santa_run_sponsorship 0.5000 2021-12-16 https://www.cslbehring.co.jp/newsroom/2021/210225_csl_2021hy_results 0.5000 2021-04-16 https://www.cslbehring.co.jp/newsroom/2021/210303_home_delivery 0.5000 2021-04-16 https://www.cslbehring.co.jp/newsroom/2021/210402_csl_covid19_fact_sheet 0.5000 2021-04-19 https://www.cslbehring.co.jp/newsroom/2021/210402_covid19_update 0.5000 2021-06-15 https://www.cslbehring.co.jp/newsroom/2021/210402_covig19_alliance 0.5000 2021-04-19 https://www.cslbehring.co.jp/newsroom/2021/210409_world_hemophilia_day_2021 0.5000 2021-04-08 https://www.cslbehring.co.jp/newsroom/2022/220114_csl830_nda_submission 0.5000 2022-01-16 https://www.cslbehring.co.jp/newsroom/2022/220210_hemb_website_renewal 0.5000 2022-02-10 https://www.cslbehring.co.jp/newsroom/2022/220218_rdd 0.5000 2022-02-18 https://www.cslbehring.co.jp/newsroom/2022/220225_csl_2122hy_results 0.5000 2022-02-25 https://www.cslbehring.co.jp/newsroom/2022/220415_whd2022_hem_site_renewal 0.5000 2022-04-15 https://www.cslbehring.co.jp/newsroom/2022/220513_hae_day_promise_movie 0.5000 2022-05-13 https://www.cslbehring.co.jp/newsroom/2022/220614_hae_info_center_site_renewal 0.5000 2022-06-14 https://www.cslbehring.co.jp/newsroom/2022/220817_csl_2122fy_results 0.5000 2022-08-19 https://www.cslbehring.co.jp/newsroom/2022/221206_great_santa_run_2022 0.5000 2022-12-22 https://www.cslbehring.co.jp/newsroom/2022/btsc_approval_jpn_press_release_221121 0.5000 2022-11-21 https://www.cslbehring.co.jp/newsroom/2022/btsc_nhi_drugprice_press_release_221116 0.5000 2022-11-16 https://www.cslbehring.co.jp/newsroom/2022/220126_covid19_update 0.5000 2022-02-07 https://www.cslbehring.co.jp/newsroom/2023/1h23-asx-release-final_jp_final 0.5000 2023-02-27 https://www.cslbehring.co.jp/newsroom/2023/20230119_csl_behring_hizentra_launched_csl_igg_support_navi 0.5000 2023-01-26 https://www.cslbehring.co.jp/newsroom/2023/20230126_csl_behring_raise_awareness_of_intractable_diseases_and_support_patients 0.5000 2023-01-26 https://www.cslbehring.co.jp/newsroom/2023/20230308_european_commission_approves_csls_hemgenix_first_gene_therapy_for_hemophilia_b 0.5000 2023-03-09 https://www.cslbehring.co.jp/newsroom/2023/20230316_csl_announces_phase_3_results_of_first-in-class_garadacimab 0.5000 2023-03-16 https://www.cslbehring.co.jp/newsroom/2023/20230412-csl-mosaic-art-press-release 0.5000 2023-11-21 https://www.cslbehring.co.jp/newsroom/2023/20230421_csl_behring_hemophilia_healthcare_hackathon_held 0.5000 2023-04-20 https://www.cslbehring.co.jp/newsroom/2023/20230601_csl_behring_for_patients_with_hereditary_angioedema 0.5000 2023-11-21 https://www.cslbehring.co.jp/newsroom/2023/20230626_human_immunoglobulin_preparation 0.5000 2024-08-16 https://www.cslbehring.co.jp/newsroom/2023/20230824_csl_announces_full_year_2023_results 0.5000 2023-11-21 https://www.cslbehring.co.jp/newsroom/2023/20230929_izumi_yoshida_appointed_as_president_and_representative_director_of_csl_bering 0.5000 2023-11-14 https://www.cslbehring.co.jp/newsroom/2023/20231003_csl_behring_and_alfresas_special_patient_home_delivery_service 0.5000 2023-11-21 https://www.cslbehring.co.jp/newsroom/2023/20231106_csl_behring_supporting_patients_with_rare_and_intractable_diseases_and_their_families 0.5000 2023-11-21 https://www.cslbehring.co.jp/newsroom/2023/20231113_prix_galien_usa 0.5000 2023-11-14 https://www.cslbehring.co.jp/newsroom/2023/20231127_csl_behring_project_to_support_children_fighting_illness_sponsoring 0.5000 2023-11-28 https://www.cslbehring.co.jp/newsroom/2023/20231129_ministry_of_health_labor_and_welfare_recommends 0.5000 2023-11-29 https://www.cslbehring.co.jp/newsroom/2023/20231206_csl_behring_hereditary_angioedema_hae 0.5000 2023-12-06 https://www.cslbehring.co.jp/newsroom/2024/08082024-human-immunoglobulin-preparation-for-subcutaneous-injection 0.5000 2024-08-16 https://www.cslbehring.co.jp/newsroom/2024/12042024_april_17_th_is_world_hemophilia_day 0.5000 2024-04-14 https://www.cslbehring.co.jp/newsroom/2024/18012024_regarding-support-for-those-affected-by-the-2020-noto-peninsula-earthquake 0.5000 2024-01-19 https://www.cslbehring.co.jp/newsroom/2024/19112024_csl_pro 0.5000 2024-11-19 https://www.cslbehring.co.jp/newsroom/2024/20240516_hae-day 0.5000 2024-05-16 https://www.cslbehring.co.jp/newsroom/2024/20240819_position-statement 0.5000 2024-08-19 https://www.cslbehring.co.jp/newsroom/2024/20240822-full-year-results 0.5000 2025-02-11 https://www.cslbehring.co.jp/newsroom/2024/20241205_2024-santa-parade 0.5000 2024-12-05 https://www.cslbehring.co.jp/newsroom/2024/22012024_csl-behring-human-immunoglobulin-preparation 0.5000 2024-08-16 https://www.cslbehring.co.jp/newsroom/2024/22022024_csl_behring_supports_rare_disease_day_2024 0.5000 2024-08-16 https://www.cslbehring.co.jp/newsroom/2024/21022024_csl-2024-first-half-financial-report-net-profit 0.5000 2024-02-21 https://www.cslbehring.co.jp/newsroom/2025/01092025_npata 0.5000 2025-10-16 https://www.cslbehring.co.jp/newsroom/2025/03032025_hae 0.5000 2025-10-16 https://www.cslbehring.co.jp/newsroom/2025/09122025_santa-parade-2025 0.5000 2025-12-09 https://www.cslbehring.co.jp/newsroom/2025/15102025_sms 0.5000 2025-10-15 https://www.cslbehring.co.jp/newsroom/2025/17042025_hae 0.5000 2025-10-16 https://www.cslbehring.co.jp/newsroom/2025/19022025_npata 0.5000 2025-02-19 https://www.cslbehring.co.jp/newsroom/2025/20022025_hae 0.5000 2025-10-16 https://www.cslbehring.co.jp/newsroom/2025/20250911_hae 0.5000 2025-10-16 https://www.cslbehring.co.jp/newsroom/2025/22072025_gene-therapy-door 0.5000 2025-10-16 https://www.cslbehring.co.jp/newsroom/2025/22122025_new-england-journal-of-medicine 0.5000 2025-12-19 https://www.cslbehring.co.jp/newsroom/2025/27022025_rare-disease-day-2025 0.5000 2025-02-27 https://www.cslbehring.co.jp/newsroom/2025/28072025_rare-link-project 0.5000 2025-10-16 https://www.cslbehring.co.jp/newsroom/2025/go-red-for-women-japan 0.5000 2025-02-03 https://www.cslbehring.co.jp/newsroom/2026/18032026_npata 0.5000 2026-03-20 https://www.cslbehring.co.jp/newsroom/2026/29012026_rare-disease-day-2026 0.5000 2026-01-29 https://www.cslbehring.co.jp/newsroom/2018/20181225-csl-behring-sponsors-great-santa-run 0.5000 2018-12-25 https://www.cslbehring.co.jp/newsroom/2018/20181214-hemophilia-healthcare-hackathon-press-release 0.5000 2018-12-14 https://www.cslbehring.co.jp/newsroom/2018/20181129-dosing-period-limitation-of-afstyla-lifted 0.5000 2018-11-29 https://www.cslbehring.co.jp/newsroom/2018/20181204-cslb-japan-website-relaunch 0.5000 2021-02-18 https://www.cslbehring.co.jp/newsroom/2018/idelvion-3500-approved 0.5000 2018-11-14 https://www.cslbehring.co.jp/newsroom/2018/20180906-nishihin 0.5000 2018-11-14 https://www.cslbehring.co.jp/newsroom/2018/20180815-csl-full-year-results 0.5000 2018-11-14 https://www.cslbehring.co.jp/newsroom/2018/20180524-sumahoapuri 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2018/20180425-hemophilia-navigator 0.5000 2018-11-15 https://www.cslbehring.co.jp/newsroom/2018/20180413--world-hemophilia-day 0.5000 2018-11-26 https://www.cslbehring.co.jp/newsroom/2018/20180406-tissue-adhesion-and-closure-during-surgery 0.5000 2018-11-14 https://www.cslbehring.co.jp/newsroom/2018/20180316-hizentra-approved-for-treatment-of-cidp 0.5000 2018-11-14 https://www.cslbehring.co.jp/newsroom/2018/20180315-hizentra-approved-as-treatment-for-cidp-by-commission 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2018/20180223-csl-behring-sponsors-rare-disease-day-2018 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2018/20180214-csl-limited-announces-results-for-half-year-2018 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2017/20170215-csl-limited-announces-profits-from-2016 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2017/20170216-csl-behring-funds-aid-for-study-abroad 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20170222-csl-behring-sponsors-rare-disease-day-2017 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2017/20170322-csl-behring-sponsors-climate-marathon-and-festival-2017 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20170324-csl-behring-acquires-berinert-therapy-for-hereditary-angioedema 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20170330-csl-behring-acquires-manufacturing-and-marketing-approval-for-kcentra 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20170410-csl-behring-donates-on-world-hemophilia-day 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20170816-csl-net-profits-2017 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2017/20170828-csl-behring-acquires-calimune 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2017/20170915-new-launch-of-kcentra 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20170927-acquisition-of-manufacturing-and-marketing-approval-for-afstyla-therapy-for-hemophilia-a 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20171109-hizentra-cidp-clinical-trial-results 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2017/20171130-new-smartphone-app-for-hemophilia-patients 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20171130-tips-for-tomorrow-for-hemophilia-patients 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20171201--idelvion-prescription-days-limitation-cancelled 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2017/20171201-new-afstyla-therapy-for-hemophilia-a 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160216-csl-limited-2015-16-first-half-performance-announcement 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2016/20160304-csl-behring-announces-idelvion-approved-by-us-fda 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2016/20160414-csl-behring-commits-to-treatment-of-hemophila-at-whd 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2016/20160418-earthquake-announcement 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160425-csl-100th-anniversary 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160426-csl-behring-renews-hae-information-center 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160511-csl-behring-announces-fda-approval-of-7-year-distribution-right-for-idelvion 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2016/20160511-csl-behring-announces-idelvion-approved-by-european-commission 0.5000 2021-02-12 https://www.cslbehring.co.jp/newsroom/2016/20160526-csl-behring-announces-fda-approval-of-afstyla 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160726-csl-behring-afstyla-hemophilia-a-2016-world-congress 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160727-csl-behring-clinical-trial-of-idelvion-for-hemophilia-b-at-world-conference-2016 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160817-csl-limited-announces-full-year-results-for-2015-16 0.5000 2018-11-14 https://www.cslbehring.co.jp/newsroom/2016/20160825-csl-behring-files-application-to-manufacture-and-market-new-drugs-in-japan 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160923-closure-and-relocation-of-yashio-factory 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20160928-csl-behring-announceds-idelvion-approval-for-manufacturing-and-marketing 0.5000 2018-09-07 https://www.cslbehring.co.jp/newsroom/2016/20161129-csl-behring-announces-release-of-idelvion 0.5000 2018-09-07 https://www.cslbehring.co.jp/contact-us/inquiry 0.5000 2022-09-07 https://www.cslbehring.co.jp/contact-us/recruiting 0.5000 2018-10-02